-
May 27, 2022 5 Next-Generation Psychedelics Entering Clinical Trials This YearModernized psychedelic medicine is coming, whether you like it or not, so here are five...
-
May 13, 2022 Psychedelic Business Spotlight – May 13This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the...
-
April 29, 2022 Why Field Trip Health Is Dividing in Two — and What This Means for InvestorsField Trip Health plans to split into two independent, publicly traded companies: Field Trip Health...
-
April 29, 2022 Psychedelic Business Spotlight – April 29This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences...
-
April 8, 2022 Psychedelic Business Spotlight – April 8This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs...
-
March 10, 2022 My Favorite Psychedelic Stocks: Part 1Our resident Psychedelic Investor details five companies he thinks are in strong position to win...
-
March 4, 2022 Psychedelic Business Spotlight – March 4This week in psychedelic business news: Field Trip partners with Cerebral; Benzinga forms Psychedelic Advisory...
-
February 25, 2022 Psychedelic Business Spotlight – February 25This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon;...
-
January 14, 2022 Psychedelic Business Spotlight — January 14This week in psychedelic business news: Another psychedelics company starts trading on OTCQB; another ketamine...
-
January 7, 2022 Is ‘The Trip’ Essential to The Psychedelic Experience?Biology and experience are tough to separate, but some researchers are exploring the possibility of...
